FDMT
4D Molecular Therapeutics Inc
14.50$
-1.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | -297.3% | – | – | – | – | – | – | – | |
| – | +11.3% | +44.0% | +43.7% | +109.3% | +28.5% | +48.2% | +16.6% | +13.7% | |
| – | +437.9% | +157.2% | +40.8% | +176.9% | +24.1% | +14.9% | +32.8% | -15.7% | |
| – | +367.5% | +532.5% | -42.1% | +190.9% | +16.5% | – | – | – | |
| – | -147.3% | – | -374.9% | – | – | – | -14.8% | +1,049.3% | |
| – | -27.7% | +673.7% | -68.8% | +811.0% | +26.6% | -76.0% | +36.6% | -85.8% | |
| – | -105.4% | +673.7% | -68.8% | +17,168.0% | -90.1% | – | -361.4% | -69.3% | |
| – | – | – | +12,152.2% | – | -100.4% | – | – | – | |
| – | +528,506.3% | -102.6% | – | -57.7% | -97.4% | +4,983.7% | +115.0% | -66.5% | |
| – | +326.4% | -162.0% | – | -154.5% | – | – | -150.7% | – | |
| – | -317.5% | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.